A Study to Evaluate Efficacy and Safety of AVTX-803 in Patients With Leukocyte Adhesion Deficiency Type II
Clinical trial NCT05462587 · RECRUITING
Trial details
- NCT number
- NCT05462587
- Sponsor
- AUG Therapeutics
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-28
- Primary completion
- 2026-11-30
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.